Stay updated on Durvalumab Combo in Pleural Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Pleural Mesothelioma Clinical Trial page.

Latest updates to the Durvalumab Combo in Pleural Mesothelioma Clinical Trial page
- ChecktodayChange DetectedVersion 72 is now listed with a return date of 2026-08-31 and a QC status of Has Not Concluded. The update also adds new sections for Outcome Measures (Results) and Document Section to the study record history.SummaryDifference0.4%

- Check7 days agoChange DetectedThe page history shows a new revision, v3.6.6, replacing the previous v3.6.5, indicating a minor update to the page version in the history.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedVersion 3.6.5 was added on 2026-08-04. The update introduces Adverse Events and Outcome Measures (Results) and notes that Quality Control Review has not concluded, with related changes to Study Status and document sections.SummaryDifference0.4%

- Check43 days agoChange DetectedRevision: v3.6.4 is now displayed on the page, replacing the previous v3.6.3. This reflects a new build of the ClinicalTrials.gov interface without changing the study record content or user-facing functionality.SummaryDifference0.0%

- Check64 days agoChange DetectedThe study record history now shows a Returned: 2026-06-30 entry with Quality Control Review Has Not Concluded and adds new sections such as More Information, Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and Document Section under Study Status. It also updates the record to Revision: v3.6.3 from v3.6.2.SummaryDifference0.6%

- Check71 days agoChange DetectedThe page now shows Revision: v3.6.2 in the footer, replacing the previous v3.6.0. This reflects a new site build/version without changing study history content.SummaryDifference0.0%

Stay in the know with updates to Durvalumab Combo in Pleural Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Pleural Mesothelioma Clinical Trial page.